Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,854 | 13,140 | 13,920 | 15,472 | 12,611 |
| Receivables | 1,631 | 1,855 | 1,504 | 1,219 | 1,308 |
| Inventories | 2,589 | 1,894 | 1,861 | 1,851 | 2,143 |
| Other current assets | 1,024 | 1,116 | 1,038 | 1,158 | 1,163 |
| TOTAL | $18,098 | $18,005 | $18,323 | $19,700 | $17,225 |
| Non-Current Assets | |||||
| PPE Net | 1,314 | 1,547 | 1,812 | 2,278 | 2,552 |
| Investments And Advances | 280 | 289 | 297 | 308 | 324 |
| Intangibles | 4,557 | 4,612 | 4,668 | 801 | 4,779 |
| Other Non-Current Assets | 500 | 548 | 582 | 4,571 | 729 |
| TOTAL | $6,651 | $6,996 | $7,359 | $7,958 | $8,384 |
| Total Assets | $24,749 | $25,001 | $25,682 | $27,658 | $25,609 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,705 | 2,634 | 2,564 | 2,497 | 2,047 |
| Accounts payable and accrued liabilities | 5,478 | 3,999 | 3,912 | 4,395 | 5,088 |
| TOTAL | $8,183 | $6,633 | $6,476 | $6,892 | $7,135 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,790 | 3,399 | 3,974 | 4,520 | 5,044 |
| Other Non-Current Liabilities | 7,412 | 4,756 | 4,450 | 2,947 | 2,060 |
| TOTAL | $20,224 | $19,791 | $20,086 | $26,489 | $26,191 |
| Total Liabilities | $28,407 | $26,424 | $26,562 | $33,381 | $33,326 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,826 | 38,754 | 36,809 | 34,089 | 29,313 |
| Common Shares | 40 | 38 | 36 | 34 | 31 |
| Retained earnings | -182,504 | -173,015 | -166,212 | -165,386 | -162,168 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 206 |
| TOTAL | $-3,658 | $-1,423 | $-880 | $-5,723 | $-7,717 |
| Total Liabilities And Equity | $24,749 | $25,001 | $25,682 | $27,658 | $25,609 |